This AI Healthcare Platform Is Taking Its New York Expansion Through 2029

1. Rocket Doctor is a billboard sponsor of Streetwise Reports and pays SWR a monthly sponsorship fee between US$3,000 and US$6,000. 
2. As of the date of this article, officers, contractors, shareholders, and/or employees of Streetwise Reports LLC (including members of their household) own securities of Rocket Doctor.
3. James Guttman wrote this article for Streetwise Reports LLC and provides services to Streetwise Reports as an employee. 
4.  This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company. 
5. This article does not constitute medical advice. Officers, employees and contributors to Streetwise Reports are not licensed medical professionals. Readers should always contact their healthcare professionals for medical advice.

For additional disclosures, please click here.

1 Disclosure for the quote from the Stewart Thomson article published on March 17, 2026

1. For the quoted article (published on March 17, Rocket Doctor has paid Street Smart, an affiliate of Streetwise Reports, US$2,500
2. Author Certification and Compensation: Stewart Thomson was retained and compensated as an independent contractor by Street Smart for writing this article. Mr. Thomson is a retired Canadian financial advisor who has passed the Canadian Securities Course as well as additional technical analysis courses that were mandated by his former employer and approved by Ontario regulatory bodies. For the past 15 years, he has been editing and writing numerous financial newsletters that have a strong focus on charts.  The recommendations and opinions expressed in this content reflect the personal, independent, and objective views of the author regarding any and all of the companies discussed. No part of the compensation received by the author was, is, or will be directly or indirectly tied to the specific recommendations or views expressed.

2. Ownership and Share Structure Information

The information listed above was updated on the date this article was published and was compiled from information from the company and various other data providers.

Rocket Doctor AI Inc.'s (AIDR:CSE; AIRDF:OTC; 939:FRA) wholly owned subsidiary, Rocket Doctor, Inc., extended its engagement with EngageWell to continue providing physician-led care to underserved communities across New York following completion of the New York Health Foundation-funded "Virtual Pathway to Care" initiative.

The extended engagement took effect July 1, 2026, and aligns with the underlying grant-funded telehealth initiatives through Oct. 31, 2029. Under the renewed arrangement, Rocket Doctor and EngageWell are combining philanthropic support with Medicaid reimbursement where appropriate, while continuing to provide no-cost telemedicine services to uninsured and underinsured New Yorkers.

The initial pilot connected more than 400 underserved New Yorkers with physician-led virtual urgent care, preventive health consultations, psychiatric evaluations, and primary care navigation through community-based organizations. According to the company, the pilot exceeded its program goals.

"This next phase is about building on a model that has already demonstrated meaningful community impact," Dr. William Cherniak, co-Founder and Chief Executive Officer of Rocket Doctor, Inc., said in a company news release. "Our focus now is on creating sustainable reimbursement pathways that will allow this model to grow and become a lasting part of how health care is delivered."

The renewed engagement also complements the partners' Healthy Aging program, which is supported by funding from the CVS Health Foundation and serves adults aged 60 and older. Services include virtual heart health consultations, mental health and cognitive assessments, physician follow-up, and referrals to additional care.

That program also runs through Oct. 31, 2029. Its targets include 750 mental health assessments, 750 cognitive health assessments, and 750 heart health consultations, all provided free of cost to participants.

"For the people we serve, the greatest barrier often isn't technology — it's access," EngageWell Executive Director Christopher Joseph said in the release. "This partnership demonstrates that when trusted community organizations are equipped with modern telemedicine, we can reach people who have historically been left out of the health-care system and connect them to the care they need."

Digital Health Market Expands as AI, Telemedicine, and Workforce Readiness Shape the Sector

According to a July 19 report from MarketScale, healthcare systems faced a digital skills gap as they adopted electronic health records, AI-assisted diagnostics, and remote patient monitoring. A review of 20 digital health competency assessment tools found that nearly half had been designed exclusively for nurses, while only two met validity standards across an interprofessional workforce. MarketScale wrote that "current digital competency tools in healthcare do not adequately cover the full workforce" and said improved measurement and development of digital skills were needed across clinical and public health teams.

MarketScale also cited a separate review that identified 222 digital public health competencies before refining them into 19 competencies across health data, digital public health services and functions, and analytics and artificial intelligence. The report said both studies reached a similar conclusion: "the research interest in digital health workforce capability is growing fast, but the evidence base for measuring and building it remains thin."

Market.us Media reported July 28 that digital health technologies had increasingly been used in neurological care through telemedicine, artificial intelligence, wearable devices, mobile health applications, and remote monitoring. The report valued the global digital health in neurology market at US$38 billion in 2024 and projected it to reach US$296.3 billion by 2034, representing a 22.8% compound annual growth rate from 2025 to 2034. North America accounted for more than 39.2% of the market in 2024, with a value of US$14.9 billion.

The report identified access to specialists as one factor supporting digital care models, noting a global median density of 0.43 adult neurologists per 100,000 people. Market.us Media said, "Tele-neurology platforms, AI-based diagnostic tools, and remote patient monitoring systems help extend specialist services, improve clinical decision-making, and reduce delays in treatment." It also reported that 37% of U.S. adults had used telemedicine in 2021, including 43.3% of adults aged 65 and older.

A Healthcare Foresights study released July 28 valued the broader global digital transformation in the healthcare market at approximately US$72.3 billion in 2025 and US$81.7 billion in 2026. The study covered technologies and services, including telehealth and virtual care platforms, AI and machine learning, electronic health records, healthcare analytics, cloud healthcare platforms, patient engagement, and cybersecurity.

According to Healthcare Foresights, "the demand for global digital transformation in the healthcare market size & share was valued at approximately US$72.3 billion in 2025 and is expected to reach US$81.7 billion in 2026." The research projected the market to reach approximately US$270.9 billion by 2035, representing a compound annual growth rate of about 14.13% from 2026 through 2035.

Technical Analyst Rated Rocket Doctor AI a Strong Speculative Buy

¹In a March 17 report, technical analyst Stewart Thomson assigned Rocket Doctor AI Inc. a Strong Speculative Buy technical rating, highlighting the company's AI-driven healthcare platform, expanding U.S. payer network, and physician-focused technology.

Thomson wrote that Rocket Doctor's AI platform "is designed by doctors, so doctors who use it get exactly what they need," with an approach "centered on enhancing provider capabilities, not replacing clinical decisions." The report highlighted smart triage and matching technology, remote patient monitoring, multilingual care and support across multiple specialties.

Thomson also pointed to Rocket Doctor's New York expansion, including an in-network agreement that he said brought its nationwide reach to more than 15 million members, as well as a US$1 million Healthy Aging Program grant launched with CVS Health Foundation.

Discussing the company's U.S. position, Thomson wrote that competitors face "a minimum of 18 to 24+ months to replicate the position Rocket Doctor AI is in today," citing its technology, payer contracts, credentialing, and revenue operations.

Thomson set technical price targets of CA$0.80 in the short term, CA$1.00 in the medium term, and CA$1.60 in the long term.

Payer Expansion, AI Products, and New State Markets Form Growth Plan

Near-term catalysts included continued expansion across the United States, with the company identifying Florida, Texas, and additional states as priority markets for future growth.

The company also expected to advance commercialization of its artificial intelligence platform through pharmacy kiosks, Voice AI applications, and third-party licensing of its Global Library of Medicine (GLM) API.

Rocket Doctor is also scheduled to participate in ALL IN 2026, Canada's AI conference in Montréal on September 16-17, 2026, where the company may provide updates on its technology, partnerships, and commercialization initiatives.

Rocket Doctor's presentation states that its broader plans include expansion of operations in Canada and the United States, continued work to maintain and expand payer relationships, including in-network contracts with Medicare, Medicaid, Medi-Cal, and commercial payers, and further development and commercialization of its AI-powered healthcare platform and related products.

Ownership and Share Structure²

As at July 6th 2026, Insider ownership of Rocket Doctor AI totals 4.29%. Retail investors hold the rest.

As at July 6th 2026, Rocket Doctor AI has 99.16 million shares outstanding. Its market cap is CA$59.50M. Its 52-week range is CA$0.33–0.98/share.

Frequently Asked Questions

What is Rocket Doctor AI Inc.?

Rocket Doctor AI Inc. (AIDR:CSE; AIRDF:OTC; 939:FRA) operates an AI-powered healthcare platform designed to support physicians and specialists in delivering care. Its technology includes virtual care infrastructure, AI-supported clinical workflows, patient intake and triage, physician matching, remote patient monitoring, and tools covering different stages of the patient care journey.

What did Rocket Doctor AI announce about its partnership with EngageWell in New York?

Rocket Doctor AI's wholly owned subsidiary, Rocket Doctor, Inc., extended its engagement with EngageWell to continue expanding access to physician-led care for underserved communities across New York. The extended agreement took effect July 1, 2026, and aligned with underlying grant-funded telehealth initiatives through Oct. 31, 2029.

How is Rocket Doctor expanding telemedicine access for underserved New Yorkers?

Rocket Doctor and EngageWell are combining philanthropic support with Medicaid reimbursement where appropriate while continuing to provide no-cost telemedicine services to uninsured and underinsured New Yorkers. The initial "Virtual Pathway to Care" pilot connected more than 400 underserved New Yorkers with virtual urgent care, preventive health consultations, psychiatric evaluations, and primary care navigation.

What is Rocket Doctor AI's Healthy Aging program?

The Healthy Aging program, supported by funding from the CVS Health Foundation, serves adults aged 60 and older through virtual heart health consultations, mental health and cognitive assessments, physician follow-up, and referrals to additional care. The current program period extends through Oct. 31, 2029.

How many health assessments and consultations are planned through Rocket Doctor's Healthy Aging program?

The program has targets of 750 mental health assessments, 750 cognitive health assessments, and 750 heart health consultations. The services are provided free of cost to participants.

How does Rocket Doctor AI use artificial intelligence in healthcare?

Rocket Doctor AI's July 2026 investor overview described a connected suite of AI healthcare tools supporting patient intake, patient visits and follow-up. The platform includes AI Nurse, RD Connect, Health Voyager, ClinBot, and other tools supporting functions such as symptom-based intake, patient and doctor matching, diagnostic support, referrals, labs, imaging, and follow-up.

What is Rocket Doctor AI's Global Library of Medicine?

The Global Library of Medicine, or GLM, is part of Rocket Doctor AI's healthcare technology platform. According to the company's July 2026 investor overview, it had been developed since 2016 with more than 25,000 hours of input from hundreds of clinicians globally and approximately 10,000 or more expert medical reviews. The company said it covered more than 1,000 diseases and 17,000 symptoms in real time.

How large is Rocket Doctor AI's healthcare network?

The company's July 2026 investor overview reported more than 750,000 patients seen and more than 350 physicians. It also reported approximately 21 million in-network patients through payer partners across its U.S. operations.

Where does Rocket Doctor AI operate?

The July 2026 investor overview identified operations in New York, California, and Maryland in the United States and Alberta, British Columbia, and Ontario in Canada. The presentation also identified Florida, Texas, and other states as part of its U.S. expansion pipeline.

What did analyst Stewart Thomson say about Rocket Doctor AI stock?

In a March 17 report, technical analyst Stewart Thomson assigned Rocket Doctor AI a Strong Speculative Buy technical rating. He set a short-term technical price target of CA$0.80, a medium-term technical target of CA$1.00, and a long-term technical target of CA$1.60.

How large is the digital transformation in the healthcare market?

Healthcare Foresights valued the global digital transformation in the healthcare market at approximately US$72.3 billion in 2025 and US$81.7 billion in 2026. Its July 28 research projected the market to reach approximately US$270.9 billion by 2035, representing a compound annual growth rate of about 14.13% from 2026 through 2035.

What technologies are driving digital transformation in healthcare?

Healthcare Foresights identified areas including artificial intelligence and machine learning, telehealth and virtual care, electronic health records, healthcare analytics, cloud healthcare platforms, patient engagement, cybersecurity, and the Internet of Medical Things among the technologies and solutions covered by the digital healthcare transformation market.

How are AI and telemedicine being used in healthcare?

Digital healthcare applications described in the sector research included AI-assisted clinical decision-making, virtual consultations, remote patient monitoring, patient intake, electronic health record integration, and continuous monitoring. Market.us Media also identified growing use of telemedicine, artificial intelligence, wearable devices, and remote monitoring in neurological care.

Why are digital health and virtual care platforms important for healthcare access?

The sector research identified specialist shortages and access to care among factors associated with the adoption of digital healthcare models. Market.us Media reported a global median density of just 0.43 adult neurologists per 100,000 people and said tele-neurology, AI-based diagnostic tools, and remote patient monitoring helped extend access to specialist services.

What is the outlook for the AI healthcare and digital health sector?

The research provided for this article described continued adoption of AI, telemedicine, remote patient monitoring, and other digital healthcare technologies. Healthcare Foresights projected the broader digital transformation in the healthcare market to reach approximately US$270.9 billion by 2035, while Market.us Media projected the digital health in the neurology market to reach US$296.3 billion by 2034.